First Quadrant’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-3,100
| Closed | -$16K | – | 515 |
|
|
2021
Q3 | $16K | Sell |
3,100
-40,100
| -93% | -$207K | ﹤0.01% | 500 |
|
|
2021
Q2 | $273K | Sell |
43,200
-43,600
| -50% | -$276K | 0.03% | 311 |
|
|
2021
Q1 | $671K | Buy |
86,800
+35,601
| +70% | +$275K | 0.07% | 221 |
|
|
2020
Q4 | $335K | Sell |
51,199
-8,201
| -14% | -$53.7K | 0.03% | 302 |
|
|
2020
Q3 | $395K | Sell |
59,400
-11,159
| -16% | -$74.2K | 0.05% | 247 |
|
|
2020
Q2 | $588K | Buy |
+70,559
| New | +$588K | 0.08% | 240 |
|
|
2018
Q3 | – | Sell |
-9,748
| Closed | -$223K | – | 849 |
|
|
2018
Q2 | $223K | Sell |
9,748
-5,718
| -37% | -$131K | ﹤0.01% | 577 |
|
|
2018
Q1 | $440K | Sell |
15,466
-3,482
| -18% | -$99.1K | 0.01% | 502 |
|
|
2017
Q4 | $400K | Buy |
18,948
+10,437
| +123% | +$220K | 0.01% | 583 |
|
|
2017
Q3 | $155K | Sell |
8,511
-1,835
| -18% | -$33.4K | ﹤0.01% | 747 |
|
|
2017
Q2 | $160K | Buy |
+10,346
| New | +$160K | ﹤0.01% | 712 |
|